Skip to main content
HCPCS Q0224 · Level II · Part B drug

Q0224: pemivibart, HCPCS Level II drug code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for Q0224

Billing unit
4500 MG
Inj, pemivibart, 4500 mg
ASP payment limit
$7,615.20
October 2026; +5.2% vs July 2026
Practitioner MUE
1
MAI 3
OPPS status
SI L
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS Q0224 is the Level II code for Injection, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, and who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, and are unlikely to mount an adequate immune response to covid-19 vaccination, 4500 mg, billed per 4500 MG. The Medicare Part B ASP payment limit for October 2026 is $7,615.20 per billing unit, up 5.2% from July 2026. The practitioner MUE allows up to 1 units per date of service (MAI 3), so a full 1-unit day is $7,615.20 at the current limit. Under OPPS it carries status indicator L. Q0224 is billed in units of 4500 MG; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. No current Billing and Coding Article lists Q0224, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for Q0224 at $7,615.20 per 4500 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $7,239.00 in July 2026. Beneficiary coinsurance is 0%.

ASP payment limits for Q0224
QuarterPayment limitPerCoinsurance
October 2026$7,615.204500 MG0%
July 2026$7,239.004500 MG—
CMS note: See COVID-19 vaccine pricing webpage for payment effective dates

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk lists no NDC for Q0224. Report the NDC from the product label and confirm the units conversion from the HCPCS descriptor (Injection, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, and who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, and are unlikely to mount an adequate immune response to covid-19 vaccination, 4500 mg).

Medically Unlikely Edits (MUE)

CMS publishes 2 MUE values for Q0224. For practitioners the limit is 1 unit per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for Q0224 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services13 Date of Service Edit: ClinicalPrescribing Information
Facility outpatient hospital13 Date of Service Edit: ClinicalPrescribing Information

MUE for Q0224 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists Q0224 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check Q0224 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

Q0224 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists Q0224 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, Q0224 carries status indicator L. The OPPS status indicator reference explains how status L is paid.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), Q0224 carries payment indicator L1, which CMS defines as "Influenza vaccine; pneumococcal vaccine. Packaged item/service; no separate payment made". No separate national ASC rate is published for it.

Common denials for Q0224 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for Q0224

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS Q0224

What does HCPCS code Q0224 describe?

Q0224 is defined by CMS as "Injection, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, and who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, and are unlikely to mount an adequate immune response to covid-19 vaccination, 4500 mg". Each billing unit represents 4500 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is Q0224 a CPT code?

No. Q0224 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as pemivibart; CPT codes are five-character codes maintained by the AMA. On a Part B claim Q0224 reports the drug itself in 4,500 mg units, and the administration is billed on its own line.

What is the Medicare reimbursement for Q0224 in October 2026?

The ASP-based payment limit is $7,615.20 per 4500 MG, with 0% beneficiary coinsurance. The July 2026 limit was $7,239.00. Commercial payers use their own fee schedules.

How many units of Q0224 can be billed per day?

The practitioner Medically Unlikely Edit is 1 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Prescribing Information" as the rationale.

Does Q0224 have NCCI bundling edits?

No active practitioner PTP pairs list Q0224 as a column-1 or column-2 code in the v323r0 release.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.